share_log

Roth MKM Maintains Buy on BioRestorative Therapies, Raises Price Target to $18

Benzinga ·  Aug 14 07:52  · Ratings

Roth MKM analyst Jonathan Aschoff maintains BioRestorative Therapies (NASDAQ:BRTX) with a Buy and raises the price target from $15 to $18.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment